Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 27, 2021
JRS PHARMA & Gujarat Microwax GMW 4 Manufacturing facility in Gujarat, India, was awarded an EXCiPACT Certificate for GMP.
read more
Wednesday, September 23, 2020
JRS PHARMA has announced the Rettenmaier Natural Fiber Manufacturing facilities in Changzhou, China, were awarded an EXCiPACT™ Certificate for GMP.
read more
Friday, September 25, 2020
JRS PHARMA has announced the Rettenmaier Natural Fiber Manufacturing facilities in Changzhou, China, were awarded an EXCiPACT™ Certificate for Good Manufacturing Practices (GMP).
read more
Friday, December 20, 2019
JRS Pharma LP sites in Cedar Rapids, Iowa were awarded an EXCiPACT Certificate from SGS for the production of Microcrystalline Cellulose, Silicified Microcrystalline Cellulose, and Dextrates as well as GDP for the central logistics warehouse.
read more
Tuesday, December 06, 2022
JRS PHARMA announced the construction of a new manufacturing facility in Cedar Rapids, Iowa. Starting in the fall of 2022, with operations commencing in early 2024, the expansion will be a two-story pre-cast building that will manufacture ...
read more
Wednesday, January 28, 2015
JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, has moved to a new and expanded suite of offices and laboratories with increased manufacturing space to meet growing demand ...
read more
Jounce Therapeutics has regained the worldwide rights to JTX-8064 from Bristol Myers Squibb.
read more
Monday, December 02, 2019
Jost Chemical announced the opening of a new manufacturing facility in Poland.
read more
Wednesday, December 20, 2023
The European Medicines Agency (EMA) and the U.S. FDA have jointly unveiled the "EMA–FDA joint Q&As on Quality and GMP aspects of PRIME/Breakthrough therapy applications."
Body:
The European Medicines Agency (EMA) and the U.S. Food and Drug ...
read more
Thursday, September 22, 2016
Johnson Matthey, a provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, announced that its facilities in Annan, UK, have been approved for GMP manufacturing following an extensive program of ...
read more
Tuesday, January 28, 2014
Johnson Matthey Catalysis and Chiral Technologies (JMCCT), a business unit of Johnson Matthey Fine Chemical Division (LSE: JMAT), has announced an expansion to its proprietary tethered catalyst technology, and is now offering multi-kilogram ...
read more
Wednesday, December 03, 2014
Johnson Matthey (LSE: JMAT), a leading provider of pharmaceutical services, active pharmaceutical ingredients (APIs) and catalyst technologies, has announced completion of an acquisition of pharmaceutical manufacturing capacity in Scotland, U.K. The ...
read more
Wednesday, September 21, 2022
Johnson & Johnson opened its San Francisco Bay Campus, a state-of-the-art Research & Development (R&D) facility in the Bay Area, one of the world’s most established global hubs for innovation and entrepreneurship.
read more
Friday, September 15, 2023
Johnson & Johnson updated its brand and uniting both its medtech and pharmaceutical segments under the Johnson & Johnson brand name to demonstrate its collective power in healthcare.
read more
Wednesday, October 14, 2020
Johnson & Johnson announced the EC has approved an Advance Purchase Agreement in which the Janssen will supply 200 million doses of its COVID-19 vaccine candidate to EU Member States following approval or authorization from regulators.
read more